Kyverna Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today reported its business highlights and financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback